1. Home
  2. KALV vs LXU Comparison

KALV vs LXU Comparison

Compare KALV & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.74

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$15.36

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
LXU
Founded
N/A
1968
Country
United States
United States
Employees
N/A
513
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.0B
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
KALV
LXU
Price
$26.74
$15.36
Analyst Decision
Strong Buy
Hold
Analyst Count
5
4
Target Price
$32.60
$14.63
AVG Volume (30 Days)
4.3M
1.2M
Earning Date
07-09-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.93
EPS
N/A
0.27
Revenue
$50,000,000.00
$615,208,000.00
Revenue This Year
$185.42
$13.69
Revenue Next Year
$59.23
N/A
P/E Ratio
N/A
$55.19
Revenue Growth
495.66
17.77
52 Week Low
$9.83
$6.80
52 Week High
$26.85
$17.22

Technical Indicators

Market Signals
Indicator
KALV
LXU
Relative Strength Index (RSI) 75.30 56.47
Support Level $14.66 $7.83
Resistance Level N/A $15.59
Average True Range (ATR) 0.39 0.75
MACD 0.25 -0.00
Stochastic Oscillator 98.72 90.62

Price Performance

Historical Comparison
KALV
LXU

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: